| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/13/2005 | EP1476537B1 Container with at least one electrode |
| 07/13/2005 | EP1385559B9 Chitosan and hydroxy carboxylic acid based porous and non-porous matrices |
| 07/13/2005 | EP0804548B1 Patched genes and their use |
| 07/13/2005 | EP0681431B1 Production of human recombinant collagen in the milk of transgenic animals |
| 07/13/2005 | EP0394296B2 Assay of a body fluid for measuring bone resorption |
| 07/13/2005 | CN1639358A Multiple virus replicon culture systems |
| 07/13/2005 | CN1639353A Method for producing riboflavin |
| 07/13/2005 | CN1639345A LIS promoter for expression of transgenes in floral tissues |
| 07/13/2005 | CN1639343A Method for detection of leptin receptor ligands |
| 07/13/2005 | CN1639342A Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 07/13/2005 | CN1639338A Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 07/13/2005 | CN1639335A Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring NOTCH gene |
| 07/13/2005 | CN1639331A Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 07/13/2005 | CN1639323A Vesicles derived from T cells, production and uses |
| 07/13/2005 | CN1639195A Selective targeting of tumor vasculature using antibody molecules |
| 07/13/2005 | CN1639192A Anti-human tenascin monoclonal antibody |
| 07/13/2005 | CN1638822A Compositions comprising undifferentiated fetal cells for the treatment of skin disorders |
| 07/13/2005 | CN1638800A Human monoclonal antibodies against CD30 |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1638792A FGFR agonists |
| 07/13/2005 | CN1638783A Treatment of muscular distrophy with cord blood cells |
| 07/13/2005 | CN1638775A Nitric oxide donors for treatment of disease and injury |
| 07/13/2005 | CN1638765A Mediators of Hedgehog signaling pathways, compositions and uses related thereto |
| 07/13/2005 | CN1638640A Human fetal bladder-derived epithelial cells |
| 07/13/2005 | CN1638622A Heat stable mutants of starch biosynthesis enzymes |
| 07/13/2005 | CN1637143A Correlation gene for generating synthetic cholesterol synthetic inhibitor monakalin k |
| 07/13/2005 | CN1637137A Method of inducing stem cell to differentiate to insulin-like cell and its application |
| 07/13/2005 | CN1637136A Laser prepn process of directionally arranged nanometer channel regulating cell |
| 07/13/2005 | CN1636594A Angiostatin and use of the same for inhibition of angiogenesis |
| 07/13/2005 | CN1210404C Acetohydroacid synthase promoter for expression of introduced genes in plants |
| 07/13/2005 | CN1210403C Method for producing biotin |
| 07/13/2005 | CN1210402C Broad-spectrum delta-enotoxins |
| 07/13/2005 | CN1210401C Compound from moraxella catarrhalis |
| 07/13/2005 | CN1210309C Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them |
| 07/13/2005 | CN1210288C Method of extracting DNA from spermatophore of fish |
| 07/13/2005 | CN1210066C Cloning pigs using donor nuclei from differentiated cells |
| 07/12/2005 | US6916976 Regulation of gene expression in plants |
| 07/12/2005 | US6916975 Transgenic seeds for propagating disease, insect, heat and drought tolerant plants |
| 07/12/2005 | US6916971 Comprises nucleotide sequences coding glutamic acid transfer RNA reductase for identifying effective nontoxic herbicides; enzyme inhibitors |
| 07/12/2005 | US6916916 Chinese hamster ovaries defective in expression of neuramidase activity for producing glycoproteins with intact carbohydrate chains; antisense agents |
| 07/12/2005 | US6916913 Dorsalin-1 polypeptide and uses thereof |
| 07/12/2005 | US6916907 Comprises osteoclastogenesis inhibitory factor (OCIF) polypeptide for diagnosis and treatment of bone disorders |
| 07/12/2005 | US6916786 Especially Keratinocyte Growth Factor 12; accelerating wound healing and treating gastrointestinal and respiratory disorders. |
| 07/12/2005 | US6916783 Proliferation of chondrocytes to increase the biosynthesis of collagen administering angiotensinogen, angiotensin I and II including analogues, fragments and analogues and type 2 receptor agonists; amino acid sequences; kits |
| 07/12/2005 | US6916782 Gene coding for heliomicine and use thereof |
| 07/12/2005 | US6916656 Using electrical pulse to merge and/or make porous cells; cancer imunotherapy; nuclear transplantation; hybridoma cultures |
| 07/12/2005 | US6916655 Artifical skin for use in the grafting, tissue reconstruction or regenerative medicines |
| 07/12/2005 | US6916648 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/12/2005 | US6916640 Multi-layer cell encapsulation for tissue engineering |
| 07/12/2005 | US6916632 Generation of preferential configured nucleotide sequences; obtain nucleotide sequences, incubate with topoisomerase, link sequences and recover products |
| 07/12/2005 | US6916631 Comprises monoclonal antibody for diagnosis and treatment of skin disorders |
| 07/12/2005 | US6916629 Tissue factor pathway inhibitor-3 |
| 07/12/2005 | US6916627 ATM kinase compositions and methods |
| 07/12/2005 | US6916625 Artery- and vein-specific proteins and uses therefor |
| 07/12/2005 | US6916624 Antibody for use in the diagnosis and treatment of cancer |
| 07/12/2005 | US6916615 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 07/12/2005 | US6916607 Gene controlling androgen |
| 07/12/2005 | US6916603 Administering a test agent; monitoring expression of Delta FosB to determine whether the agent modulates bone formation |
| 07/12/2005 | US6916477 Vaccine containing attenuated virus; induction antibodies; veterinary medicine |
| 07/12/2005 | US6916475 Anti-idiotypic antibody and its use in regulating the composition of T cell lymphocytes |
| 07/12/2005 | US6916470 Methods for use of mpl ligands with primitive human stem cells |
| 07/12/2005 | CA2452172A1 Methods and compositions for modulating cell activation and uses thereof |
| 07/12/2005 | CA2432123C Preservation of cells |
| 07/12/2005 | CA2374388C The use of ribozymes in the detection of adventitious agents |
| 07/12/2005 | CA2222718C Attachment enhanced 293 cells |
| 07/07/2005 | WO2005061697A1 Process for producing engineered targeted t cell and medicine |
| 07/07/2005 | WO2005061696A1 Method for isolating cells from mammary secretion |
| 07/07/2005 | WO2005061695A1 Method for isolating cells from mammary secretion |
| 07/07/2005 | WO2005061694A1 Drug testing system with bio-artificial liver |
| 07/07/2005 | WO2005061545A2 Nogoa antibodies for the treatment of alzheimer disease |
| 07/07/2005 | WO2005061544A2 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 07/07/2005 | WO2005061541A1 Anti-igf-i receptor antibody |
| 07/07/2005 | WO2005061019A2 Methods and composition for soft tissue feature reconstruction |
| 07/07/2005 | WO2005061018A1 Matrix comprising naturally-occurring protein backbone |
| 07/07/2005 | WO2005060740A2 An improved method for embryo and animal production |
| 07/07/2005 | WO2005060592A2 Process for producing t lymphocytes |
| 07/07/2005 | WO2005060553A2 Geraniol synthase, methods of production and uses thereof |
| 07/07/2005 | WO2005060396A2 Nanotopographic compositions and methods for cellular organization in tissue engineered structures |
| 07/07/2005 | WO2005047493A3 Nanofibrillar structure and applications including cell and tissue culture |
| 07/07/2005 | WO2005042728A3 Immortalized avian cell lines for virus production |
| 07/07/2005 | WO2005042693A3 Hla-e chimeric molecule |
| 07/07/2005 | WO2005028640A8 Method for isolating hepatocytes |
| 07/07/2005 | WO2005021025A3 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION |
| 07/07/2005 | WO2005016114A3 Generation of living tissue constructs in vivo using a mold |
| 07/07/2005 | WO2005010139A3 Ferromagnetic cell and tissue culture microcarriers |
| 07/07/2005 | WO2004099364A3 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells |
| 07/07/2005 | WO2004078909A3 Identification of antigen epitopes |
| 07/07/2005 | WO2004022579A3 Cellular delivery of natriuretic peptides |
| 07/07/2005 | WO2003089583A3 Tissue specific genes and gene clusters |
| 07/07/2005 | WO2003083069A8 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 07/07/2005 | US20050150011 Viral amplification of recombinant messenger RNA in transgenic plants |
| 07/07/2005 | US20050150006 Biodegradable high oxidative stability oils |
| 07/07/2005 | US20050149999 Methods for cloning mammals using remodeling factors |
| 07/07/2005 | US20050149996 Generation of chicken cell lines from embryonic stem cells and germ cells |
| 07/07/2005 | US20050149994 Rapidly maturing fluorescent proteins and methods for using the same |
| 07/07/2005 | US20050149993 Transgenic mouse for use as model in identifying modulators for prevention and treatment of circadian rythm disorders |
| 07/07/2005 | US20050148526 Methods of obtaining isoform specific expression in mammalian cells |
| 07/07/2005 | US20050148513 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 07/07/2005 | US20050148078 Bovine immunodeficiency virus (BIV) based vectors |
| 07/07/2005 | US20050148077 Bovine immunodeficiency virus (BIV) based vectors |